These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 31237451)

  • 21. The relationship between bile acid concentration, glucagon-like-peptide 1, fibroblast growth factor 15 and bile acid receptors in rats during progression of glucose intolerance.
    Yan X; Li P; Tang Z; Feng B
    BMC Endocr Disord; 2017 Sep; 17(1):60. PubMed ID: 28946907
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Difference in postprandial GLP-1 response despite similar glucose kinetics after consumption of wheat breads with different particle size in healthy men.
    Eelderink C; Noort MWJ; Sozer N; Koehorst M; Holst JJ; Deacon CF; Rehfeld JF; Poutanen K; Vonk RJ; Oudhuis L; Priebe MG
    Eur J Nutr; 2017 Apr; 56(3):1063-1076. PubMed ID: 26857762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Asynchronous rhythms of circulating conjugated and unconjugated bile acids in the modulation of human metabolism.
    Al-Khaifi A; Straniero S; Voronova V; Chernikova D; Sokolov V; Kumar C; Angelin B; Rudling M
    J Intern Med; 2018 Nov; 284(5):546-559. PubMed ID: 29964306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of meal composition on postprandial glucagon-like peptide-1, insulin, glucagon, C-peptide, and glucose responses in overweight/obese subjects.
    Shah M; Franklin B; Adams-Huet B; Mitchell J; Bouza B; Dart L; Phillips M
    Eur J Nutr; 2017 Apr; 56(3):1053-1062. PubMed ID: 26759261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Response of fibroblast growth factor 19 and bile acid synthesis after a body weight-adjusted oral fat tolerance test in overweight and obese NAFLD patients: a non-randomized controlled pilot trial.
    Friedrich D; Marschall HU; Lammert F
    BMC Gastroenterol; 2018 Jun; 18(1):76. PubMed ID: 29866129
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The hepatic response to FGF19 is impaired in patients with nonalcoholic fatty liver disease and insulin resistance.
    Schreuder TC; Marsman HA; Lenicek M; van Werven JR; Nederveen AJ; Jansen PL; Schaap FG
    Am J Physiol Gastrointest Liver Physiol; 2010 Mar; 298(3):G440-5. PubMed ID: 20093562
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subjects with high fasting insulin also have higher postprandial GLP-1 and glucagon levels than controls with lower insulin.
    Albinsson-Stenholm E; Bergsén J; Ingves S; Vilhelmsson N; Guldbrand H; Nystrom FH
    Nutr Res; 2019 Dec; 72():111-120. PubMed ID: 31759769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Postprandial Plasma Concentrations of Individual Bile Acids and FGF-19 in Patients With Type 2 Diabetes.
    Sonne DP; van Nierop FS; Kulik W; Soeters MR; Vilsbøll T; Knop FK
    J Clin Endocrinol Metab; 2016 Aug; 101(8):3002-9. PubMed ID: 27270475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential effects of saturated and monounsaturated fatty acids on postprandial lipemia and incretin responses in healthy subjects.
    Thomsen C; Rasmussen O; Lousen T; Holst JJ; Fenselau S; Schrezenmeir J; Hermansen K
    Am J Clin Nutr; 1999 Jun; 69(6):1135-43. PubMed ID: 10357731
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Venous blood provides lower glucagon-like peptide-1 concentrations than arterialized blood in the postprandial but not the fasted state: Consequences of sampling methods.
    Chen YC; Edinburgh RM; Hengist A; Smith HA; Walhin JP; Betts JA; Thompson D; Gonzalez JT
    Exp Physiol; 2018 Sep; 103(9):1200-1205. PubMed ID: 29947441
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Postprandial Dyslipidemia, Hyperinsulinemia, and Impaired Gut Peptides/Bile Acids in Adolescents with Obesity.
    Higgins V; Asgari S; Hamilton JK; Wolska A; Remaley AT; Hartmann B; Holst JJ; Adeli K
    J Clin Endocrinol Metab; 2020 Apr; 105(4):1228-41. PubMed ID: 31825485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of chenodeoxycholic acid on the secretion of gut peptides and fibroblast growth factors in healthy humans.
    Meyer-Gerspach AC; Steinert RE; Keller S; Malarski A; Schulte FH; Beglinger C
    J Clin Endocrinol Metab; 2013 Aug; 98(8):3351-8. PubMed ID: 23783097
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FGF 19 and Bile Acids Increase Following Roux-en-Y Gastric Bypass but Not After Medical Management in Patients with Type 2 Diabetes.
    Sachdev S; Wang Q; Billington C; Connett J; Ahmed L; Inabnet W; Chua S; Ikramuddin S; Korner J
    Obes Surg; 2016 May; 26(5):957-65. PubMed ID: 26259981
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elucidating the glucose-lowering effect of the bile acid sequestrant sevelamer.
    Nerild HH; Brønden A; Haddouchi AE; Ellegaard AM; Hartmann B; Rehfeld JF; Holst JJ; Sonne DP; Vilsbøll T; Knop FK
    Diabetes Obes Metab; 2024 Apr; 26(4):1252-1263. PubMed ID: 38151760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lowered fasting chenodeoxycholic acid correlated with the decrease of fibroblast growth factor 19 in Chinese subjects with impaired fasting glucose.
    Zhang J; Li H; Zhou H; Fang L; Xu J; Yan H; Chen S; Song Q; Zhang Y; Xu A; Fang Q; Ye Y; Jia W
    Sci Rep; 2017 Jul; 7(1):6042. PubMed ID: 28729691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential effects of saturated and monounsaturated fats on postprandial lipemia and glucagon-like peptide 1 responses in patients with type 2 diabetes.
    Thomsen C; Storm H; Holst JJ; Hermansen K
    Am J Clin Nutr; 2003 Mar; 77(3):605-11. PubMed ID: 12600850
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating bile acids in healthy adults respond differently to a dietary pattern characterized by whole grains, legumes and fruits and vegetables compared to a diet high in refined grains and added sugars: A randomized, controlled, crossover feeding study.
    Ginos BNR; Navarro SL; Schwarz Y; Gu H; Wang D; Randolph TW; Shojaie A; Hullar MAJ; Lampe PD; Kratz M; Neuhouser ML; Raftery D; Lampe JW
    Metabolism; 2018 Jun; 83():197-204. PubMed ID: 29458053
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gallbladder Dyskinesia Is Associated With an Impaired Postprandial Fibroblast Growth Factor 19 Response in Critically Ill Patients.
    Koelfat KVK; Plummer MP; Schaap FG; Lenicek M; Jansen PLM; Deane AM; Olde Damink SWM
    Hepatology; 2019 Jul; 70(1):308-318. PubMed ID: 30933374
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Minor Contribution of Endogenous GLP-1 and GLP-2 to Postprandial Lipemia in Obese Men.
    Matikainen N; Björnson E; Söderlund S; Borén C; Eliasson B; Pietiläinen KH; Bogl LH; Hakkarainen A; Lundbom N; Rivellese A; Riccardi G; Després JP; Alméras N; Holst JJ; Deacon CF; Borén J; Taskinen MR
    PLoS One; 2016; 11(1):e0145890. PubMed ID: 26752550
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GLP-1 response to sequential mixed meals: influence of insulin resistance.
    Rebelos E; Astiarraga B; Bizzotto R; Mari A; Manca ML; Gonzalez A; Mendez A; Martinez CA; Hurwitz BE; Ferrannini E
    Clin Sci (Lond); 2017 Dec; 131(24):2901-2910. PubMed ID: 29097626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.